The Case for Value-Based Content Management

In these days of productivity gains and cost reduction at all costs, is what you are optimizing driving value to your customers? Are you maximizing ROI with your content and translation processes, but delivering content used most as doorstops and paperweights?

This presentation draws heavily upon the example of JD Edwards, a company that set the bar in how to efficiently single-source content, reuse it across multiple deliverables and outputs, and get it into target languages. JDE's optimized processes became the poster child for the localization industry and its single-source methodology became the model of best practices for content management thought leaders. Yet, in order to drive value to the customer and the bottom line, JDE had to shift from a cost-based optimization model to a value-based strategy.

Using this case study, we will trace the thought processes that led to the value-based breakthrough and then apply the system dynamic analysis to abstract the factors into a model that can be applied to other applications.

The Case for Value-Based Content Management was presented by Ben Martin, Partner, with Industrial Wisdom and aired on 2004-12-16. For more details or to purchase a download, please visit our site www.fxconferences.com

Risk Mitigation and Prevention in Real-Life Trials

Managing and preventing risk is an integral part of managing any clinical trial. This presentation showcases a series of real-life examples, and explore ways to leverage sophisticated tools and proactive approaches to managing project-related risk. Naturally, a flexible approach customized to each individual case is required, and this presentation shows how to go about it.

Acknowledging the need for continuous mitigation of project related risks, the speaker also explains and demonstrates methods for overcoming challenges that may occur mid-study, successfully absorbing and minimizing the impact to timelines and resources.

Risk Mitigation and Prevention in Real-Life Trials was presented by Jill Johnston, Senior Director, Project Management & Clinical Ops, with Covance and aired on 2007-04-05. For more details, or to purchase a recording, please visit our site www.fxconferences.com

Challenges Encountered & Lessons Learned in the New EU (IVD)

On May 1, 2004, the European Union expanded from 15 to 25 member states with the addition of Poland, Hungary, the Czech Republic, Slovenia, Slovakia, Malta, Cyprus, Estonia, Latvia and Lithuania. One year after these accession countries became full EU members, what has the experience been like for the IVD industry? What have been the toughest challenges to overcome? What has industry learned along the way?

This presentation examines those questions, as well as the current regulatory issues affecting IVD manufacturers in Europe.

Challenges Encountered & Lessons Learned in the New EU (IVD) was presented by Karen Howes, Director of Regulatory Affairs, with European Diagnostics Manufacturers Association and aired 2005-07-14. For more details or to purchase a download of this event, please visit our site www.fxconferences.com

State of Readiness? XML in the Life Sciences

The life sciences industry is being thrust into the world of XML. FDA's recently mandated Structured Product Labeling (SPL) initiative as well as private initiatives with Standard Response Letters, Clinical Data, and Product Information Management (PIM) for EMEA labeling have made it clear that the use of XML is on the upswing. But how do you benchmark your organization with your peers? What are the biggest problems in working with documentation?

ForeignExchange Translations, RWD Technologies, and Data Conversion Laboratory asked these questions to a broad cross-section of the life sciences industry through a comprehensive survey. In this presentation we unveil the results, looking at where the industry stands on XML initiatives, and where it needs to be. You learn how your peers are tackling the issues associated with SPL, Standard Response Letters, and Clinical Data Reports. You hear what they report as the biggest problems, and what they are doing to solve them.

State of Readiness? XML in the Life Sciences was presented by Don Bridges, Commercial Technical Documents Manager, of Data Conversion Laboratory (DCL) & Joe Jenkins, Life Sciences Market Director, of RWD Technologies and aired 2006-11-30. For more details or to purchase a download, please visit our site www.fxconferences.com

Navigating the European Human Tissue Maze

The European regulatory requirements over the past 10 years covering products using human tissue has been more than a little confused. Excluded from the Medical Device Directive, and not always appropriate to pharmaceutical rules, product manufacturers have had to deal with a raft of national regulations ranging from 'non-regulation' to 'medicines regulation'.

Although pan-European regulation has been mooted, the confusion is set to continue for at least two more years. In this audio conference, Phil Brown describes how this maze of regulation came about, as well as how the current European map offers opportunities for product introduction.

Navigating the European Human Tissue Maze was presented by Phil Brown, Sr. Consultant, with Quintiles Consulting on 2005-02-09. For more details on this conference, or to purchase a download, please visit our site www.fxconferences.com